CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 443 filers reported holding CRISPR THERAPEUTICS AG in Q4 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,511,805 | +138.3% | 33,307 | +194.7% | 0.06% | +141.7% |
Q2 2023 | $634,438 | -88.6% | 11,301 | -90.8% | 0.02% | -89.6% |
Q1 2023 | $5,543,344 | +147.1% | 122,559 | +122.1% | 0.23% | +94.1% |
Q4 2022 | $2,243,352 | +463.7% | 55,187 | +770.0% | 0.12% | +600.0% |
Q1 2022 | $398,000 | +24.4% | 6,343 | +121.4% | 0.02% | -26.1% |
Q3 2021 | $320,000 | -50.5% | 2,865 | -45.9% | 0.02% | -61.7% |
Q1 2021 | $646,000 | – | 5,300 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |